Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2–21 years …

S Sadeghi, Y Kalantari, S Shokri, M Fallahpour… - Journal of Clinical …, 2022 - Elsevier
Children and adolescents form a large proportion of societies and play an important role in
the transmission of COVID-19. On the other hand, their education, mental and physical …

[HTML][HTML] Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis

J Yin, Y Chen, Y Li, C Wang, X Zhang - International Journal of Infectious …, 2022 - Elsevier
Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity

SG Tangye, L Abel, S Al-Muhsen, A Aiuti… - Journal of Allergy and …, 2023 - Elsevier
Since the arrival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
December 2019, its characterization as a novel human pathogen, and the resulting …

COVID-19 and inborn errors of immunity

OM Delmonte, R Castagnoli, LD Notarangelo - Physiology, 2022 - journals.physiology.org
Inborn errors of immunity (IEI) are a heterogeneous group of disorders affecting immune
host defense and immunoregulation. Considering the predisposition to develop severe and …

SARS-CoV-2 T cell response in severe and fatal COVID-19 in primary antibody deficiency patients without specific humoral immunity

S Steiner, T Schwarz, VM Corman, L Gebert… - Frontiers in …, 2022 - frontiersin.org
Morbidity and mortality of COVID-19 is increased in patients with inborn errors of immunity
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …

Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity

JR Durkee-Shock, MD Keller - Annals of Allergy, Asthma & Immunology, 2022 - Elsevier
Objective To update clinicians on current evidence regarding the immunogenicity and safety
of coronavirus disease 2019 (COVID-19) vaccines in patients with inborn errors of immunity …

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: Specific T cell …

N Egri, H Calderón, R Martinez, M Vazquez… - Frontiers in …, 2023 - frontiersin.org
Background Humoral and cellular immune responses are known to be crucial for patients to
recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected …

Immune responses 6 months after mRNA-1273 COVID-19 vaccination and the effect of a third vaccination in patients with inborn errors of immunity

LPM Van Leeuwen, M Grobben… - Journal of clinical …, 2023 - Springer
Purpose Patients with inborn errors of immunity (IEI) are at increased risk of severe
coronavirus disease-2019 (COVID-19). Effective long-term protection against COVID-19 is …

Effectiveness of COVID-19 vaccination on reduction of hospitalizations and deaths in elderly patients in Rio Grande do Norte, Brazil

AIL Sales-Moioli, LJ Galvão-Lima, TKB Pinto… - International journal of …, 2022 - mdpi.com
Since the COVID-19 pandemic emerged, vaccination has been the core strategy to mitigate
the spread of SARS-CoV-2 in humans. This paper analyzes the impact of COVID-19 …

SARS-CoV-2 infection and response to COVID-19 vaccination in patients with primary immunodeficiencies

R Paris - The Journal of Infectious Diseases, 2023 - academic.oup.com
Primary immunodeficiencies (PIDs) are heterogeneous, rare disorders that increase
susceptibility to infection and/or immune dysregulation. Individuals with certain PIDs are at …